3 ASX 300 shares just upgraded by top brokers

ASX 300 shares have opened stronger amid various broker updates today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • ASX 300 shares have opened stronger amid various broker updates today
  • Analysts have raised their ratings on Webjet and Sigma Health shares 
  • However, there are diverging views on ASX Ltd shares 

S&P/ASX 300 (ASX: XKO) shares opened stronger amid various broker updates today.

ASX 300 shares are currently up 0.21% at the time of writing.

Let's see what's news with the ASX experts.

a man sits in unhappy contemplation staring at his computer on his desk in a home environment, propping his chin on his hand.

Image source: Getty Images

Brokers alter ratings on this trio of ASX 300 shares

According to The Australian, analysts are split on the virtue of investing in the Australian share market operator ASX Ltd (ASX: ASX) today.

This follows the company releasing an update at its investor day yesterday.

At the event, ASX management increased its cost guidance and lowered its dividend payout ratio for FY24.

Despite this, investment group CSLA has raised its rating on ASX shares to accumulate with a $65.50 price target.

ASX shares are trading at $61.12 at the time of writing, implying a potential upside of 7% for new investors who buy today.

However, other brokers have turned on the stock.

UBS has cut ASX shares to a sell rating with a 16% target price reduction to $59. Jarden Securities has cut its rating to neutral with a $64.85 price target.

Morgan Stanley has cut its price target by 36% to $62.40. Citi has also cut its price target on ASX shares by 9% to $64.

Turning to ASX 300 healthcare shares, Shaw and Partners has raised its rating on Sigma Healthcare Ltd (ASX: SIG) shares to a buy.

This follows the stock's 22% surge yesterday after the pharmacy operator and supplier announced a new $3 billion deal with Chemist Warehouse.

The companies also renewed a contract that was generating approximately $1 billion in sales for Sigma.

As part of the deal, Chemist Warehouse will receive a 10.7% stake in Sigma Health.

Sigma Health shares are up another 1.55% this morning to 78.7 cents.

In other news, Jarden Securities has raised its rating on ASX 300 travel share Webjet Limited (ASX: WEB) to overweight.

Webjet shares also opened stronger but slipped back to trade even at the time of writing at $7.22 a share.

Conversely, First Sentier appears to believe it's time to reduce Webjet shares.

A change in substantial holding notice posted yesterday shows the investment group reduced its stake in the online travel agency from 12.78% to 11.73% last Friday.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

Could these ASX stocks really be set to double after crashing this week?

These companies are expected to rebound.

Read more »

A man in a sweatshirt holds two different phones to compare telco services.
Broker Notes

Forget Rio Tinto and buy this ASX copper share

Bell Potter thinks this stock could be a good alternative to the mining giant.

Read more »

A happy couple drinking red wine in a vineyard.
Broker Notes

2 ASX 200 shares newly upgraded this week

After major company news this week, one stock fell 39% while the other spiked 17%.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on CBA shares

A leading analyst forecasts headwinds for CBA shares. But why?

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »